Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. - Test2 - elhamkhani - TriplyDB

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

http://www.wikidata.org/entity/Q35609244

about

Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography 11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion Insight into the Molecular Imaging of Alzheimer's Disease PET Imaging of Epigenetic Influences on Alzheimer's Disease Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease Development of positron emission tomography β-amyloid plaque imaging agents Evaluating and treating neurobehavioral symptoms in professional American football players: Lessons from a case series.The Eye As a Biomarker for Alzheimer's Disease The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Validation of the new consensus criteria for the diagnosis of corticobasal degeneration Frontotemporal Dementia.Current neuroimaging techniques in Alzheimer's disease and applications in animal models Early-onset Alzheimer's disease versus frontotemporal dementia: resolution with genetic diagnoses?Imaging frontotemporal lobar degeneration.Multimodality imaging of Alzheimer disease and other neurodegenerative dementias Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Future Directions in Imaging Neurodegeneration.Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.Three-Class Differential Diagnosis among Alzheimer Disease, Frontotemporal Dementia, and Controls.Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions.Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography.Early detection of Alzheimer's disease using PiB and FDG PET A review of neuroimaging biomarkers of Alzheimer's disease.Molecular imaging of Alzheimer disease pathology Neuroimaging in frontotemporal dementia.Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.Prodromal posterior cortical atrophy: clinical, neuropsychological, and radiological correlation.Novel plasma biomarker surrogating cerebral amyloid deposition.A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis Modeling clustered activity increase in amyloid-beta positron emission tomographic images with statistical descriptors.Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications.Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.Advances in neuroimaging in frontotemporal dementia.Applied multimodal diagnostics in a case of presenile dementia.The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.Amyloid in dementia associated with familial FTLD: not an innocent bystander.Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.Added Diagnostic Value of (11)C-PiB-PET in Memory Clinic Patients with Uncertain Diagnosis

P2860

Q21146623-7766C6C7-B98E-47AA-9048-A9035C5E0527 Q24194742-5A514B41-D0FA-444B-90A8-072B50CC2EEE Q24633898-2484B784-B0F2-425E-86D3-6D88B69D913A Q26765945-0893EA35-6EC4-42D6-BF23-06E98A82CFC6 Q26776178-FEE739F0-683B-4C12-A814-C30C2138ED71 Q27009411-BA5746A6-814B-4FD5-A4B6-27BFDC57ED50 Q27012742-54661940-043E-494B-ACCD-C6114C048CEF Q27312607-B6B6FAA7-9C82-4BDF-925D-D18F7D00DBE2 Q28070142-6DF7ECEE-F1D5-4A32-AA94-5A875EED3EF5 Q28485924-DDF6063C-DC25-4271-8321-345EBD5FFCBF Q28655239-E8B6FE78-D271-435D-92D0-16FDEEC672EF Q30234793-ED380072-C675-4134-A827-8A406981CC07 Q30576714-6961CB78-1209-49A4-A771-0F62CA3B0E6C Q30703922-B64746C7-2A09-4A1A-80F4-A7EE500109F2 Q30846573-75C61056-0419-4F49-A5CE-592B95740D6F Q30870819-C80661D4-9C8C-4CC6-92B2-688DE1354955 Q30996799-0AA58522-7FA3-4ED6-8701-0CBB76E93AB0 Q31162702-DF20859D-4BD6-49A4-8F17-30BC56E1128D Q33610029-4C29B2B0-CBF5-43A9-86C7-AB228E841619 Q33633805-630AD60C-3C0D-4A13-BC8A-50E53CA04696 Q34275490-9B406127-BA24-4453-B6E3-103AFBE5973C Q34378321-C03F69AE-9C35-45AD-9D5E-B37C0DE55F39 Q34483878-16859FB5-E929-4E78-A345-7936DBC032FB Q34571189-9AF8089F-5D68-4381-AE34-2DC951CDBA6E Q34651135-D7B24673-1AD0-4CEF-A8CB-F87642891FE2 Q34682550-81774218-D876-4529-9442-7868D7E10973 Q34988649-C9B648D3-AE27-4DA6-A707-3A31DE6A5ACE Q35054365-37AAF615-EF28-41CE-995B-8355F816B141 Q35074431-97ACFAA6-8537-4069-9FA7-FEAD0413C48B Q35158547-E3C843EA-0D27-4ED4-9CF7-EF6492DCEC70 Q35535470-EBDE7559-259B-4851-A6C3-36761672EF77 Q35840614-AD8FE3DC-52E3-4B28-94BF-42736569753B Q36034391-31C8D842-9A24-46B0-8DBF-55D6EEB3139A Q36062457-0248C117-F1B4-4A86-85D3-C3ED4844C16B Q36097857-53CFEC03-5F3F-4B28-9C62-84EFC7B0B8EB Q36099506-20D1BAD8-A361-4BCF-B5ED-58ED1E709083 Q36217479-5344B657-D178-42BE-9783-F098DF649E58 Q36327682-4CCFC03C-C7DA-46E4-924D-8AAAD038B83D Q36526176-EB8110C1-CED4-471A-B21D-F410B0F1887D Q36551323-94BD036C-5B69-46B9-90DF-F338C03912A1

P2860

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

http://www.wikidata.org/entity/Q35609244

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

@ast

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

@en

type

label

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

@ast

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

@en

prefLabel

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

@ast

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

@en

P1433

Q35609244-A03ECD45-EDE1-4112-A3DC-57D3A30904DA

P1476

Q35609244-18DD7193-E886-48E6-862A-772BF91DAA43

P2093

Q35609244-1E6B61AE-103E-4E71-ABE5-CE7FEF16A8CA

Q35609244-2DFD9621-D566-4FA4-82A4-A61CC1B7BCD8

Q35609244-2E5BEE4B-0707-4B2A-9370-710164799CAE

Q35609244-2E9C2324-DED7-4931-8317-E3EF378DA2DE

Q35609244-310A5E8C-FDC5-440D-A3E8-109C72864E78

Q35609244-41E424F0-BAC3-4480-AFDC-2B7565B443B9

Q35609244-499BA169-A9C0-4B5D-96AD-ECAB4A1B4877

Q35609244-5BD24F45-81EC-42DE-95C0-D5F12D49C2C5

Q35609244-740DE264-4806-45E1-BC5D-9CA93A4EA64C

Q35609244-7CA93939-C326-4BED-AB2E-D8D945112F18

P2860

Q35609244-10CAEE51-A2D2-41D9-A0D6-0DD50053115E

Q35609244-158E341D-EA6B-43DB-8DE8-4D5615DA4589

Q35609244-236730AD-334A-4922-BB66-7F86E468EB8F

Q35609244-2A16208E-E886-415A-AD4B-D60B54F71E41

Q35609244-2E9E0717-4AB5-4E26-86A5-56B3E20F28A8

Q35609244-31C77F27-E84E-4774-8890-3562B867FCA4

Q35609244-324A39DE-BB51-4B8B-9763-FEE78E7E5B29

Q35609244-39562A76-9D66-4CFA-AC3C-5F23F649D36A

Q35609244-3C885A2B-8391-434B-B65C-C26B0B73A605

Q35609244-3F2363AA-5EC1-432B-86B0-78290D8CBD51

P304

Q35609244-5C02A827-30B3-4E26-A5CC-62789D905BBA

P31

Q35609244-1B9FA179-1F59-465E-8C26-2DBA9771CB24

P356

Q35609244-29F0D07A-E36E-42A2-AC5E-83235A2819D7

P407

Q35609244-2A502347-244F-4983-A955-B4DC1405CC17

P433

Q35609244-671C996B-AE1B-4F7A-B48F-6E29EF0CC9A0

P478

Q35609244-1339DAE3-A699-43EB-8816-92749AF8768F

P50

Q35609244-1403C424-D256-4355-B038-C5A1EA9D0A38

P577

Q35609244-1B403168-0670-401B-BD90-E3FC55D7BBC3

P698

Q35609244-C5B196FF-1EB2-44B4-88BF-25ADF028D210

P932

Q35609244-E171EC20-A225-4265-9089-247A103B5978

P356

WNL.0B013E31823B9C5E

P1433

P1476

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

@en

P2093

A Alkalay

http://www.w3.org/2001/XMLSchema#string

A J Furst

http://www.w3.org/2001/XMLSchema#string

A Karydas

http://www.w3.org/2001/XMLSchema#string

B L Miller

http://www.w3.org/2001/XMLSchema#string

E C Mormino

http://www.w3.org/2001/XMLSchema#string

E J Huang

http://www.w3.org/2001/XMLSchema#string

G D Rabinovici

http://www.w3.org/2001/XMLSchema#string

H J Rosen

http://www.w3.org/2001/XMLSchema#string

J Kornak

http://www.w3.org/2001/XMLSchema#string

J P O'Neil

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Focal cortical presentations of Alzheimer's disease

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro.

Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia

Pathologically proven frontotemporal dementia presenting with severe amnesia.

P304

2034-2042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E31823B9C5E

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P50

Maria Luisa Gorno-Tempini

P577

2011-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22131541

http://www.w3.org/2001/XMLSchema#string

P932

3236517

http://www.w3.org/2001/XMLSchema#string